Hualin Yu

Hualin Yu

Auto-generated profile, based on publicly available information

Hualin Yu

Second Department of Neurosurgery, First Affiliated Hospital of Kunming Medical University, Kunming, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2018 in Neuroscience Bulletin
Verified
Journal Article
Closed access
PDF file
RQRenli Qi
Renli Qi
JLJinghui Li
Jinghui Li
XWXujun Wu
Xujun Wu
XGXin Geng
Xin Geng
NCNanhui Chen
Nanhui Chen
HYHualin Yu
Hualin Yu

24 July 2020 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
RQRenli Qi
Renli Qi
XGXin Geng
Xin Geng
BHBaihui Huang
Baihui Huang
YCYe Chen
Ye Chen
HJHonggao Jiang
Honggao Jiang
HYHualin Yu
Hualin Yu
Parkinson's disease (PD) is a progressive neurodegenerative disorder, and the rate of progression is different across individuals. Subthalamic nucleus deep brain stimulation (STN-DBS) has been shown to produce long-term symptom improvement in PD. In this retrospective study, we wanted to explore the effects of bilateral STN-DBS in PD patients with different rates of disease progression. Forty patients with PD were included. An index of progression rate was calculated by the ratio of the Unified Parkinson Disease Rating Scale, part III (UPDRS-III), score in the off-medication condition at baseline and disease duration. The patients were divided into fast-, medium-, and slow-progression groups by this index. The outcome measurements at the 1st, 6th, and 12th months after surgery were the changes in UPDRS-III scores in the off-medication/on-stimulation condition compared with the baseline. We found the following. (1). Motor functions in the different PD progression groups were improved by bilateral STN-DBS treatment at 1 year of follow-up. (2). However, compared to the slow- and medium-progression groups, the fast-progression group had less improvement at the 6th- and 12th-month follow-up. The results indicated that bilateral STN-DBS can improve motor functions of Parkinson's patients over the 1-year follow-up. Moreover, the outcomes in the slow- and medium-progression patients were better than those with fast-progression rates.